Home » Topics » Regulatory » Patents

Patents
RSS

5-HT2B/2C antagonists reported by SmithKline Beecham

June 14, 1996

Further ADIR research on melatonergic compounds

June 14, 1996

CCK-A agonists revealed by Glaxo Wellcome

June 14, 1996

Monsanto reveals benzothiazepines with novel activity

June 14, 1996

ACAT inhibitors from Sankyo

June 14, 1996

Hyperlipidemia treatment from Takeda

June 14, 1996

Fujisawa reveals FR-177391, agent for cachexia in cancer patients

June 14, 1996

The Salk Institute for Biological Studies reveals immunophilin proteins

June 14, 1996

Astra reports autoimmune disease treatment agents

June 14, 1996

Sankyo reports anti-HIV-1 oligodeoxyribonucleotides

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.